Blocking the molecular source of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is one of the most challenging and frustrating diseases that pulmonologists face. Despite affecting 1 out of 200 adults over the age of 65 in the United States, general awareness of IPF is low. …